Skip to main content
OpenTrials

Clinical trial condition

Progressive Pulmonary Fibrosis

Explore clinical trials studying Progressive Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

20 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Progressive Pulmonary Fibrosis trial results

Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

NCT06951217

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • Renstar Medical Research Ocala, Florida, United States
View all 72 locations
View Trial Details
Recruiting

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

NCT06238622

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 373 locations
View Trial Details
Recruiting

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

NCT06855329

Conditions
Interstitial Lung Disease, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Massachusetts Chan Medical School Worcester, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Texas Southwestern Dallas, Texas, United States
  • University of Virginia Charlottesville, Virginia, United States
View all 24 locations
View Trial Details
Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

NCT05943535

Conditions
Interstitial Lung Disease, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • UAB Lung Health Center Birmingham, Alabama, United States
  • Banner University Medical Center Phoenix Lung Institute Phoenix, Arizona, United States
  • Norton Thoracic Institute Phoenix, Arizona, United States
  • Peter Morton Medical Building Los Angeles, California, United States
View all 165 locations
View Trial Details

Related conditions